À¯¹æ¾Ï ¾×ü »ý°Ë ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ¼øÈ¯ ¹ÙÀÌ¿À¸¶Ä¿º°, ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Breast Cancer Liquid Biopsy Market Size, Share & Trends Analysis Report By Circulating Biomarkers (Circulating Tumor Cells, Circulating Cell-free DNA, Extracellular Vesicles), By Application, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1587471
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 120 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

À¯¹æ¾Ï ¾×ü »ý°Ë ½ÃÀå ¼ºÀå ¹× µ¿Çâ:

¼¼°è À¯¹æ¾Ï ¾×ü »ý°Ë ½ÃÀå ±Ô¸ð´Â 2030³â 19¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 8.5%ÀÇ ¼ºÀå·üÀ» ±â·ÏÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

ÀÌ·¯ÇÑ ¼ºÀåÀÇ ¹è°æ¿¡´Â ºñħ½ÀÀû ¹æ¹ý¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡, Á¶±â Áø´Ü ¹× Ä¡·á¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, À¯¹æ¾Ï À¯º´·üÀÇ Áõ°¡°¡ ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é 2020³â Àü ¼¼°èÀûÀ¸·Î 685,000¸íÀÇ ¿©¼ºÀÌ À¯¹æ¾ÏÀ¸·Î »ç¸ÁÇϰí 230¸¸ ¸íÀÇ ¿©¼ºÀÌ À¯¹æ¾Ï¿¡ °É¸± °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù. ¾×ü »ý°ËÀº À¯¹æ¾ÏÀ» Á¶±â¿¡ ¹ß°ßÇÒ ¼ö Àִ ȹ±âÀûÀÎ ±â¼ú·Î Á¦¾ÈµÇ°í ÀÖÀ¸¸ç, À̴ äÅÃÀ» ÃËÁøÇÏ°í ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

À¯¹æ¾ÏÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¾ÏÀÇ Á¶±â ¹ß°ß°ú Á¶±â Ä¡·á¸¦ À§ÇÑ ÀûÀýÇÑ Áø´Ü µµ±¸ÀÇ Á¦°øÀÌ Àý½ÇÈ÷ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ Áø´Ü ºÐ¾ßÀÇ ¿¬±¸ °³¹ßÀÌ È°¹ßÈ÷ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 6¿ù ¹ÙÀÌ¿ÀÇ÷çµðÄ«(BioFluidica)ÀÇ ¿¬±¸ °á°ú¿¡ µû¸£¸é, HER2 ¾ç¼º À¯¹æ¾Ï ȯÀÚ´Â HER2 ÁöÇâ ¸ÂÃãÇü Ä¡·á¸¦ ¹ÞÀ¸¸é¼­ Ä¡·á ¼º°ø·üÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. °ü·Ã ºÐ¾ßÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ ¾×ü »ý°ËÀÇ ÀÓ»óÀû Á߿伺ÀÌ Á¡Á¡ ´õ ¸¹ÀÌ ¾Ë·ÁÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀ» ³Î¸® Ȱ¿ëÇϱâ À§Çؼ­´Â ´õ ¸¹Àº ÁßÀç ÀÓ»ó½ÃÇè°ú ¼øÈ¯ ¹ÙÀÌ¿À¸¶Ä¿¸¦ ÀûÀýÈ÷ Á¶ÇÕÇÏ´Â ¾Ë°í¸®ÁòÀÇ °³¹ßÀÌ ÇÊ¿äÇÕ´Ï´Ù.

ºñÇ÷¾× ¾Ç¼º Á¾¾çÀ» ½Äº°Çϱâ À§ÇÑ º¸´Ù ÃÖ¼Òħ½ÀÀûÀÎ ±â¼úÀº ¼øÈ¯ ¹ÙÀÌ¿À¸¶Ä¿¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¿¬±¸ÀÇ ±â¼úÀû Çõ½ÅÀÇ °á°ú·Î °³¹ßµÇ¾ú½À´Ï´Ù. ±âÁ¸ÀÇ Á¾¾ç »ý°Ë¿¡ ºñÇØ ¾×ü »ý°ËÀº ȯÀÚ¸¦ ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ´Â À¯¸ÁÇÑ ´ë¾ÈÀ¸·Î ¿©°ÜÁö°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 4¿ù Epic Sciences, Inc.´Â ÀüÀ̼º À¯¹æ¾Ï Áø´ÜÀ» À§ÇÑ ¾×ü »ý°Ë ±â¼ú ±â¹Ý Ç÷¾× °Ë»ç DefineMBC¸¦ CLIA °Ë»ç ½Ã¼³ Æ÷Æ®Æú¸®¿À¿¡ Ãß°¡Çß½À´Ï´Ù.

¶ÇÇÑ, ÀÌ ½ÃÀå¿¡¼­ Ȱµ¿ÇÏ´Â ÁÖ¿ä ±â¾÷µéÀº ´Ù¾çÇÑ ¿ëµµ·Î »ç¿ëÇÒ ¼ö ÀÖ´Â Á¦Ç°À» È®ÀåÇϰí Ãâ½ÃÇÏ´Â µ¥ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 6¿ù ³×¿ÀÁö³ë¹Í½ºÀÇ ÀÚȸ»ç ÀιÙŸ(Inivata Limited)´Â Àΰ£ »óÇǼ¼Æ÷ ¼ºÀåÀÎÀÚ ¼ö¿ëü 2(HER2) À½¼ºÀ¸·Î ¹Ì¼¼ÀÜÁ¸º´º¯(MRD)°ú Àç¹ßÀ» µ¿¹ÝÇÑ °íÀ§Ç豺 ȯÀÚ ºÐ¼®¿¡ »ç¿ëµÇ´Â RaDAR ºÐ¼®ÀÇ »õ·Î¿î µ¥ÀÌÅ͸¦ ¹ßÇ¥Çß½À´Ï´Ù.

À¯¹æ¾Ï ¾×ü »ý°Ë ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå À¯¹æ¾Ï ¾×ü »ý°Ë ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå À¯¹æ¾Ï ¾×ü »ý°Ë ½ÃÀå : ¼øÈ¯ ¹ÙÀÌ¿À¸¶Ä¿ ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå À¯¹æ¾Ï ¾×ü »ý°Ë ½ÃÀå : ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå À¯¹æ¾Ï ¾×ü »ý°Ë ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå °æÀï »óȲ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Breast Cancer Liquid Biopsy Market Growth & Trends:

The global breast cancer liquid biopsy market size is expected to reach USD 1.90 billion in 2030 and is projected to grow at a CAGR of 8.5% from 2025 to 2030. The growth is attributed to the rising preference for non-invasive methods, rising awareness of early diagnosis and treatment, and rising prevalence of breast cancer. For instance, according to WHO, in 2020, globally, 685,000 women lost their lives to breast cancer, and 2.3 million women were affected by it. Liquid biopsies have been suggested as a revolutionary technique for the early identification of breast cancer, which boosts its adoption and spurs growth.

With the increasing prevalence of breast cancer, there is a high demand to provide proper diagnostics tools for detecting cancer at an early stage and early treatment. There has been increasing R&D in the field of diagnostics to cater to the rising demand. For instance, in June 2022, according to study findings from BioFluidica, patients with HER2-positive breast cancer had success rates while receiving tailored HER2-directed therapy.The clinical significance of liquid biopsy is becoming more well-known as a result of ongoing developments in related fields. Additional interventional clinical trials and the creation of an algorithm to properly combine circulating biomarkers are required to make these technologies widely accessible.

A less intrusive technique for identifying non-hematological malignancies has been developed as a result of technological breakthroughs in continuing research on circulating biomarkers. Compared to traditional tumor biopsy, liquid biopsy is thought to be a promising option for patient monitoring in real time. For instance, in April 2022, Epic Sciences, Inc., launched DefineMBC, a blood test based on liquid biopsy technology for the diagnosis of metastatic breast cancer to its CLIA laboratory portfolio.

Furthermore, key players operating in the market are focusing on expanding and launching products that can be used for a wide range of applications. For instance, in June 2022, NeoGenomics's subsidiary Inivata Limited announced new data for RaDaR assay for the analysis of human epidermal growth factor receptor 2 (HER2)-negative, high-risk patients with minimal residual disease (MRD) and recurrence.

Breast Cancer Liquid Biopsy Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Breast Cancer Liquid Biopsy Market Variables, Trends & Scope

Chapter 4. Breast Cancer Liquid Biopsy Market: Circulating Biomarkers Estimates & Trend Analysis

Chapter 5. Breast Cancer Liquid Biopsy Market: Application Estimates & Trend Analysis

Chapter 6. Breast Cancer Liquid Biopsy Market: Regional Estimates & Trend Analysis

Chapter 7. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â